VERSACLOZ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Versacloz, and what generic alternatives are available?
Versacloz is a drug marketed by Tasman Pharma and is included in one NDA. There is one patent protecting this drug.
This drug has six patent family members in six countries.
The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the clozapine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Versacloz
A generic version of VERSACLOZ was approved as clozapine by IVAX SUB TEVA PHARMS on November 26th, 1997.
Summary for VERSACLOZ
International Patents: | 6 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Patent Applications: | 3,352 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in VERSACLOZ? | VERSACLOZ excipients list |
DailyMed Link: | VERSACLOZ at DailyMed |

Anatomical Therapeutic Chemical (ATC) Classes for VERSACLOZ
US Patents and Regulatory Information for VERSACLOZ
VERSACLOZ is protected by one US patents.
Patents protecting VERSACLOZ
Stable clozapine suspension formulation
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for VERSACLOZ
See the table below for patents covering VERSACLOZ around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2532648 | FORMULATION DE SUSPENSION STABLE DE CLOZAPINE (A STABLE CLOZAPINE SUSPENSION FORMULATION) | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2005007168 | See Plans and Pricing | |
New Zealand | 527142 | A stable suspension formulation | See Plans and Pricing |
Australia | 2004257556 | A stable clozapine suspension formulation | See Plans and Pricing |
European Patent Office | 1646393 | FORMULATION DE SUSPENSION STABLE DE CLOZAPINE (A STABLE CLOZAPINE SUSPENSION FORMULATION) | See Plans and Pricing |
Spain | 2436213 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |